AlphaHunt
Agentic AI / AI Software

RXRX Stock Analysis

Recursion Pharmaceuticals, Inc. · current price $3.19 (+2.24% today)

★★ Below Avg 45/ Alpha Score
Risk is rising; momentum is fading or fundamentals are weakening. Multiple risk indicators are firing.
LAST EARNINGS Recursion Pharmaceuticals, Inc. (RXRX)

Latest earnings

EPS
$-0.41 vs $-0.35 est · -0.2% vs estimate MISS
Revenue
$6.3M · -67.0% YoY
Stock reaction (1M)
+7.3%
Beat streak
3 of last 4 quarters

Key metrics

Alpha Score
45/100
Grade
D
Rev Growth YoY
-56.1%
30-day Momentum
+7.3%
Analyst Target
$6.64
Implied Upside
+104.4%

Latest news on RXRX

Similar stocks in Agentic AI / AI Software

TEM AI PLTR PATH SOUN BBAI

View all Agentic AI / AI Software stocks →

RXRX — frequently asked

What is RXRX's Alpha Score?

Recursion Pharmaceuticals, Inc. (RXRX) currently has a TickerMover Alpha Score of 45/100, rated ★★ Below Avg. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Recursion Pharmaceuticals, Inc. (RXRX) a buy?

TickerMover does not give buy or sell recommendations. RXRX scores 45/100 (★★ Below Avg) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is RXRX's score updated?

RXRX's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for RXRX →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com